Business

GE HealthCare and Mayo Clinic unveil GEMINI-RT: A bold research collaboration in radiation therapy and advanced cancer care

GE HealthCare and Mayo Clinic launch GEMINI-RT, a strategic initiative to personalize radiation therapy by integrating imaging, AI, and patient monitoring

articleGe Healthcare Technologies Inc.December 3, 20255/company/ge-healthcare-technologies-inc/news/ge-healthcare-and-mayo-clinic-unveil-gemini-rt-a-bold-research-collaboration-in-radiation-therapy-and-advanced-cancer-care
GE HealthCare and Mayo Clinic unveil GEMINI-RT: A bold research collaboration in radiation therapy and advanced cancer care

About this update from Ge Healthcare Technologies Inc.

[{"type":"text","content":"\n\nGE HealthCare and Mayo Clinic launch GEMINI-RT, a strategic initiative to personalize radiation therapy by integrating imaging, AI, and patient monitoring across the cancer care continuum.\n\n\nThe collaboration focuses on four pillars, automation, predictive oncology, multi-modal therapies, and outpatient monitoring, with the aim to enhance clinical outcomes, reduce clinician burnout, and accelerate innovation in radiation oncology.\n\n\n CHICAGO--(BUSINESS WIRE)--\nGE HealthCare (Nasdaq: GEHC) and Mayo Clinic today announced the GE HealthCare-Mayo Clinic Initiative in Radiation Therapy, known as GEMINI-RT, an ambitious new collaboration that aims to transform personalized radiation therapy and cancer care. Building on decades of collaboration and the original Strategic Radiology Research Collaboration signed in 2023, GEMINI-RT plans to drive innovation in prediction, planning, automation, workflow and monitoring for radiation oncology.\n\nGEMINI-RT combines Mayo Clinic’s world-class clinical and research expertise with GE HealthCare’s leading technical and engineering innovation in oncology care and radiation therapy. The initiative aims to deliver comprehensive, personalized care by exploring integrating imaging, advanced therapies, dosimetry, and patient monitoring at every step of the patient journey—from detection and diagnosis to treatment and follow-up.\n\nRadiation therapy is a cornerstone of cancer care, used in more than 50% of cases worldwide and for over 2 million U.S. patients annually1,2. Rising global cancer incidence, 19.3 million new cases in 2022, continues to drive demand for this treatment3. Through GEMINI-RT, Mayo Clinic and GE HealthCare aim to make personalized radiation therapy accessible with new initiatives such as integrating streamlined, data-driven solutions, leveraging Mayo Clinic’s clinical expertise and patient outcomes data.\n\n“GEMINI-RT is grounded in the concept of ‘twinning the patient, personalizing the beam’—a transformative approach made possible by Mayo Clinic’s extensive clinical expertise and outcomes data,” said Bryan Traughber, M.D., vice chair, innovation for radiation oncology, Mayo Clinic. “The combination of research and technological acumen could allow us to model individual patient journeys with precision, enabling radiation therapy treatments that are truly tailored to eac...

More updates from Ge Healthcare Technologies Inc.